المؤلفون: Jones, RL, Ratain, MJ, O'Dwyer, PJ, Siu, LL, Jassem, J, Medioni, J, de Jonge, Maja, Rudin, C, Sawyer, M, Khayat, D, Awada, A, de Vos-Geelen, J, Evans, TRJ, Obel, J, Brockstein, B, DeGreve, J, Baurain, JF, Maki, R, D'Adamo, D, Dickson, M, Undevia, S, Geary, D, Janisch, L, Bedard, PL, Razak, ARA, Kristeleit, R, Vitfell-Rasmussen, J, Walters, I, Kaye, SB, Schwartz, G

المصدر: Jones , RL , Ratain , MJ , O'Dwyer , PJ , Siu , LL , Jassem , J , Medioni , J , de Jonge , M , Rudin , C , Sawyer , M , Khayat , D , Awada , A , de Vos-Geelen , J , Evans , TRJ , Obel , J , Brockstein , B , DeGreve , J , Baurain , JF , Maki , R , D'Adamo , D , Dickson , M , Undevia , S , Geary , D , Janisch , L , Bedard , PL , Razak ....

مصطلحات موضوعية: /dk/atira/pure/keywords/researchprograms/AFL001000/EMCOR01, name=EMC OR-01

وصف الملف: application/pdf

الاتاحة: https://pure.eur.nl/en/publications/798050b5-bc7d-42ef-aed9-c6157496502d
https://doi.org/10.1016/j.ejca.2019.07.024
https://pure.eur.nl/ws/files/48232695/Repub_119604_O-A.pdf
http://hdl.handle.net/1765/119604

المؤلفون: Jones, R.L. (Robin L.), Ratain, M.J. (Mark), O'Dwyer, P.J. (Peter J.), Siu, R.K. (Ronald), Jassem, J., Medioni, J. (Jacques), DeJonge, M.J.A. (Maja J.), Rudin, C.M. (Charles), Sawyer, M. (Michael), Khayat, D. (David), Awada, A. (Ahmad), de Vos-Geelen, J. (Judith), Evans, T.R.J. (Jeffry), Obel, J. (Jennifer), Brockstein, B. (Bruce), DeGreve, J. (Jacques), Baurain, J.F., Maki, R.G. (Robert G.), D'Adamo, D. (David), Dickson, M.A. (Mark A.), Undevia, S. (Samir), Geary, D. (David), Janisch, L. (Linda), Bedard, P.L. (Philippe L.), Abdul Razak, A.R. (Albiruni R.), Kristeleit, R.S. (R.), Vitfell-Rasmussen, J. (Joanna), Walters, I. (Ian), Kaye, S.B. (Stan B.), Schwartz, G. (Gary)

مصطلحات الفهرس: Brivanib, FGF2 status, Ovarian cancer, Randomised discontinuation trial, Sarcomas, Solid tumours, info:eu-repo/semantics/article

URL: http://repub.eur.nl/pub/119604

المؤلفون: Benson C, Vitfell Rasmussen J, Fisher C, Tunariu N, Mitchell S, Al Muderis O, Thway K, Larkin J, Judson I., MARUZZO, MARCO

المساهمون: Benson, C, Vitfell Rasmussen, J, Maruzzo, Marco, Fisher, C, Tunariu, N, Mitchell, S, Al Muderis, O, Thway, K, Larkin, J, Judson, I.

Relation: info:eu-repo/semantics/altIdentifier/pmid/24982384; info:eu-repo/semantics/altIdentifier/wos/WOS:000338780300058; volume:34; journal:ANTICANCER RESEARCH; http://hdl.handle.net/11577/2987101; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84906328267

الاتاحة: http://hdl.handle.net/11577/2987101

المؤلفون: Benson, C., Vitfell-Rasmussen, J., MARCO MARUZZO, Fisher, C., Tunariu, N., Mitchell, S., Al-Muderis, O., Thway, K., Larkin, J., Judson, I.

المصدر: Scopus-Elsevier

مصطلحات موضوعية: Male, Sirolimus, Antibiotics, Antineoplastic, Treatment Outcome, Perivascular Epithelioid Cell Neoplasms, Humans, Antineoplastic Agents, Female, Middle Aged, Retrospective Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2a0e159f29995566806d18e8230a538c
http://hdl.handle.net/11577/2987101